GMVDF vs. TTOO, SDCCQ, VRAYQ, AFIB, NMRD, UTRS, MOTS, VIVE, DRTSW, and ANZUW
Should you be buying G Medical Innovations stock or one of its competitors? The main competitors of G Medical Innovations include T2 Biosystems (TTOO), SmileDirectClub (SDCCQ), ViewRay (VRAYQ), Acutus Medical (AFIB), Nemaura Medical (NMRD), Minerva Surgical (UTRS), Motus GI (MOTS), Viveve Medical (VIVE), Alpha Tau Medical (DRTSW), and Anzu Special Acquisition Corp I (ANZUW). These companies are all part of the "medical equipment" industry.
G Medical Innovations vs. Its Competitors
T2 Biosystems (NASDAQ:TTOO) and G Medical Innovations (NASDAQ:GMVDF) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, valuation, dividends, profitability, earnings, institutional ownership and risk.
G Medical Innovations has a net margin of 0.00% compared to T2 Biosystems' net margin of -563.16%.
G Medical Innovations has lower revenue, but higher earnings than T2 Biosystems.
23.2% of T2 Biosystems shares are held by institutional investors. Comparatively, 6.0% of G Medical Innovations shares are held by institutional investors. 0.0% of T2 Biosystems shares are held by insiders. Comparatively, 37.1% of G Medical Innovations shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
T2 Biosystems has a beta of 0.19, meaning that its share price is 81% less volatile than the S&P 500. Comparatively, G Medical Innovations has a beta of 38.96, meaning that its share price is 3,796% more volatile than the S&P 500.
In the previous week, T2 Biosystems had 1 more articles in the media than G Medical Innovations. MarketBeat recorded 1 mentions for T2 Biosystems and 0 mentions for G Medical Innovations. T2 Biosystems' average media sentiment score of 0.00 equaled G Medical Innovations'average media sentiment score.
Summary
G Medical Innovations beats T2 Biosystems on 5 of the 9 factors compared between the two stocks.
Get G Medical Innovations News Delivered to You Automatically
Sign up to receive the latest news and ratings for GMVDF and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding GMVDF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
GMVDF vs. The Competition
G Medical Innovations Competitors List
Related Companies and Tools
This page (NASDAQ:GMVDF) was last updated on 9/25/2025 by MarketBeat.com Staff
